Santhera Pharmaceuticals Holding AG is #143 in rating Capitalization on EBS.
Santhera Pharmaceuticals Holding AG earnings per share rating is determined in each financial period. “Earnings per share” is the name of the stock market parameter corresponding to the amount of income in terms of the number of shares of the company for a certain accounting interval. The “earnings per share” rating is higher if the company's earnings per share are greater.
The total income of the company in a certain accounting interval forms the basis of the Santhera Pharmaceuticals Holding AG Net Income rating. The company's income or profit for the Net Income rating does not consider the total number of shares of the company and their value. The top ranking of "Net income of the company" is usually headed by the largest and most profitable companies.